It is currently Sun Apr 20, 2014 2:04 am

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

And another story

The clinic in Holland must be turning customers away. A consultant neuro in the UK probably earns £100,000. Sacking a few would help fund treatments for MS patients. It's a sad state of affairs when the medical profession can do nothing to help someone so young in such a dreadful situation.




Woman's £15,000 bid to defeat MS 23 February 2006

A woman crippled by multiple sclerosis is hoping to raise £15,000 for what she hopes ...
Read more : And another story | Views : 1329 | Replies : 0 | Forum : Stem Cells


Another stem cell story

Not a day goes by in the UK press without an 'MS sufferer / stem cell treatment in Holland story'. Here's another. The view of the UK neuro profession seems to be that this treatment is a waste of time (and money). But in most case they don't have anything else to offer their patients.


Banned Treatment Helped Me Walk 23 February 2006
By Justine Marklew

WALKING his dog in the park, Malcolm Pear doesn't ...
Read more : Another stem cell story | Views : 1704 | Replies : 1 | Forum : Stem Cells


have you read this book ?

Has anyone read this book, he makes some claims about MS and it's treatment. I just wondered if anyone had some comments about it. Natural Cures They Don't Want You To Know About by: Kevin Trudeau, thx
Read more : have you read this book ? | Views : 1263 | Replies : 4 | Forum : General Discussion




Bone Marrow Transplantation Study Update:

Hello everybody, I have been called out to this study next month and I am very excited it is finally here. I am looking to get any input from the knowledgeable people on this site as to anything that will promote regrowth of mylein or help me through this tough procedure. I look forward to your responses.

The Multiple Sclerosis Scientific Research Foundation is funding a multi-centre project to determine definitively whether transplanting bone marrow ...
Read more : Bone Marrow Transplantation Study Update: | Views : 1532 | Replies : 3 | Forum : General Discussion


Fampridine

Does anyone know when we can expect Fampridine to be approved for MS? The person who was screening trial participants a few months ago told me that it would be later this year.
Read more : Fampridine | Views : 3570 | Replies : 7 | Forum : Drug Pipeline


neural precursor cells

Israeli scientists have injected neural precursor cells into the brains of mice with EAE with some success. One of the authors was Ben-Hur - good to see that he does more than race chariots against the Romans.



http://www.msif.org/en/research/researc ... d_neu.html
Read more : neural precursor cells | Views : 1230 | Replies : 0 | Forum : Stem Cells


laquinimod

From memory this drug is in human trials but they are still testing it on mice, with the usual good results.

But I think what they are trying to say is you can take it with the interferons - in other words double your money for the drugs companies (but will be packaged as more effective combination treatments).


http://www.msif.org/en/research/researc ... of_th.html
Read more : laquinimod | Views : 1354 | Replies : 0 | Forum : Drug Pipeline


Patent for MS Diagnosis

This was posted on the MS News website (http://www.bostoncure.org:8080) but I thought it would be prudent to post it here as well.

This is a U.S. patent that "relates generally to the field of diagnosis, treatment assessment and prognosis." By means of "Peripheral blood cell markers." It's definitely worth a read as it attempts to explain my facets of MS.

http://www.freshpatents.com/Peripheral- ... 003327.php ...
Read more : Patent for MS Diagnosis | Views : 813 | Replies : 0 | Forum : General Discussion


Another Tysabri article

Dear all,

Another Tysabri article, but it raises issues that have been discussed before - what sort of patients are enrolled into trials. Of course, the drug makers would prefer those with mild disease / early disease, then they could show that the patients didn't progress / had minimal relapses or inflammatory activity. It's a bit like some of the selective schools in the UK who only take on the brightest kids and then get ...
Read more : Another Tysabri article | Views : 1983 | Replies : 6 | Forum : Tysabri (Antegren or Natalizumab)


 

Login  •  Register


Statistics

Total posts 216429 • Total topics 22113 • Total members 13904